Popular Equipment Finance (DBA K2 Capital Group), a leader in equipment financing solutions, acquired the Epione robot. The company works with healthcare organizations across the U.S., including a cancer center that used Epione in May 2023. That cancer center now entered into a lease with K2 for the Epione system, the company announced last week.
Montpellier, France-based Quantum Surgical’s Epione, a robotic-assisted percutaneous ablation system, uses a robotic arm, a navigation system and a camera. It inserts a needle through the skin to the tumor and destroys it. Epione robot enables the early and minimally invasive treatment of abdominal tumors. It allows surgeons to treat inoperable tumors, including ones particularly hard to reach due to size or location.
Epione can treat tumors in the liver, kidney and pancreas, in addition to the lung expansion it just received. It’s treated more than 300 patients worldwide.
“The entire Quantum Surgical team is thrilled about this first acquisition in the United States,” said Bertin Nahum, president and co-founder. “Patient treatment and customer satisfaction are our priorities, and we are very proud of the positive feedback we’ve received from our users, which will help accelerate Epione’s adoption in the US territory.”
